Yingying Zhang

Search results

• 2024

  CHAPAS-4 trial: second-line anchor drugs for children with HIV in Africa

  Bwakura-Dangarembizi, M., Szubert, A. J., Mumbiro, V., Kityo, C. M., Lugemwa, A., Doerholt, K., Chabala, C., Nyathi, M., Nduna, B., Burger, D., Shakeshaft, C., Nathoo, K., Musiime, V., Yawe, I., South, A., Lungu, J., Ndebele, W., Mwamabazi, M., Griffiths, A. & Nazzinda, R. & 8 others, Zimba, K., Zhang, Y., Walker, S., Turkova, A., Walker, A. S., Bamford, A., Gibb, D. M. & Team, C.-4. T., 15 Apr 2024, medRxiv, (medRxiv).

  Research output: Working paper › Preprint

• Second-line tenofovir alafenamide for children with HIV in Africa

  Musiime, V., Szubert, A. J., Mujuru, H. A., Kityo, C., Doerholt, K., Makumbi, S., Mulenga, V., Ndebele, W., Mwamabazi, M., McIlleron, H., Bwakura-Dangarembizi, M., Natukunda, E., Linda, K. J., Monkiewicz, L., Kapasa, M., Nyathi, M., Nduna, B., South, A., Musoro, G. & Zyambo, K. & 7 others, Zhang, Y., Walker, S., Turkova, A., Walker, A. S., Bamford, A., Gibb, D. M. & Team, C.-4. T., 21 Apr 2024, medRxiv, (medRxiv).

  Research output: Working paper › Preprint